Skip to main content

Month: September 2025

CTO Realty Growth Announces Third Quarter 2025 Earnings Release and Conference Call Information

WINTER PARK, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the third quarter of 2025 after the market closes on Tuesday, October 28, 2025. A conference call to discuss its financial and operating results is scheduled for Wednesday, October 29, 2025 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.ctoreit.com or at the link provided in the event details below. To access the call by phone, please go to the registration link provided in the event details below and you will be provided with dial-in details.Event Details:Webcast: https://edge.media-server.com/mmc/p/rcgq9bs5 Registration: https://register-conf.media-server.com/register/BI713280df851f472c983314239d9025dd    We...

Continue reading

CROSSJECT presents its financial results and key highlights for the first half of 2025

Press release CROSSJECT presents its financial results and key highlights for the first half of 2025Cash position: €6.3 million, compared to €7.0 million as of December 31 2024, demonstrating the Company’s excellent control of its resources. Stable R&D investments and a €3.1 million increase in R&D reimbursements from BARDA1 for the first half of 2024, to €6.5 million, in line with the focus on regulatory development and batch manufacturing related to the registration of ZEPIZURE®. The company continued to make progress toward BARDA’s submission of its Emergency Use Authorization (EUA) application for ZEPIZURE®.Dijon, France, September 24, 2025 10:00 p.m. CET — CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing products for emergency situations based on its proprietary...

Continue reading

Raymond James Financial Reports August 2025 Operating Data

St. Petersburg, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) — Raymond James Financial, Inc. (NYSE: RJF) today reported selected operating data for August 2025, in an effort to provide timely information to investors about monthly developments in certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. “Record client assets under administration of $1.69 trillion grew 10% year-over-year and 2% over the preceding month primarily driven by higher equity markets and net asset inflows,” said CEO Paul Shoukry. “Advisor recruiting remains strong. Clients’ domestic cash sweep and Enhanced Savings Program balances of $54.2 billion declined 4% year-over-year and 1% sequentially. The investment banking pipeline continues to be robust.”Operating Data     ...

Continue reading

Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025

GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year 2025 financial results on Monday, September 29, 2025, at 5:00 p.m. ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 29, 2025, followed by the conference call. Conference Call Details Date and Time: Monday, September 29, 2025, at 5:00 p.m. ET. Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or (412) 317-5705. Live Webcast Information: Interested parties...

Continue reading

ARMOUR Residential REIT, Inc. Announces Guidance for October 2025 Dividend Rate Per Common Share

VERO BEACH, Florida, Sept. 24, 2025 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the October 2025 cash dividend for the Company’s Common Stock of $0.24 per Common share. October 2025 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateOctober 2025   $0.24   October 15, 2025   October 30, 2025Certain Tax MattersARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are...

Continue reading

Diginex Provides Update on Acquisition Strategy

LONDON, Sept. 24, 2025 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, today provided an update on its acquisition strategy. Matter DK ApS (“Matter”) On August 18, 2025, Diginex signed a definitive agreement for an all-share acquisition of Matter, an innovative ESG data company focused on delivering sustainability data and analytics solutions to the investment industry and helping financial institutions understand and communicate the sustainability of investments. Matter is based in Copenhagen, Denmark, and counts a subsidiary of NASDAQ as its main strategic investor. The transaction values the equity of Matter at $13 million, which will be paid through the issuance of Diginex ordinary shares valued at $83.77 per ordinary share, which shares are subject to an...

Continue reading

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Transaction expected to close on October 7, 2025 LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by Merck & Co., Inc. (NYSE: MRK) (“Merck”) through a wholly owned subsidiary or a nominee, today announced that its shareholders have approved the proposal for Merck to acquire Verona Pharma for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion (the “Transaction”). The Transaction is being implemented by way of a scheme of arrangement under English law (the “Scheme”) and remains subject to the...

Continue reading

Kodiak Completes Business Combination with Ares Acquisition Corporation II to Accelerate Journey as a Leading AI-Powered Autonomous Vehicle Technology Company

Kodiak AI, Inc. is expected to commence trading on Nasdaq under ticker symbols “KDK” and “KDKRW” on September 25, 2025Kodiak’s ~$2.5 billion valuation is among the largest operating company de-SPAC transactions of 2025 to dateThis milestone, together with Kodiak’s track record in deploying revenue generating autonomous technology, underscores its leadership in the autonomous vehicle sectorKodiak and Ares Acquisition Corporation II have raised over $275 million before expenses to help Kodiak accelerate its go-to-market strategyMOUNTAIN VIEW, Calif. and NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Kodiak AI, Inc. (“Kodiak” or the “Company”), a leading provider of AI-powered autonomous vehicle technology, today announced that Kodiak Robotics, Inc. successfully completed its business combination with Ares Acquisition Corporation...

Continue reading

Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

Q4 2025 Net Revenue Decreased 2.6% YoY, Increased 4.4% YoY on a 13-Week Adjusted BasisQ4 2025 Net Revenue Per Active Client Grew 3.0% YoY to $549FY 2025 Gross Margin Expanded YoY to 44.4% SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced its financial results for the fourth quarter and full fiscal year 2025, ended August 2, 2025. Please note that fiscal 2024 was a 53-week year due to an extra week in the fourth quarter. As such, the adjusted revenue growth rates referenced in these results remove the impact of that extra week to provide a comparison that the Company believes more accurately reflects its performance. “Fiscal 2025 was a milestone year for Stitch Fix. We finished the year with our second consecutive quarter of year-over-year...

Continue reading

Steelcase Reports Second Quarter Fiscal 2026 Results

Revenue grew 5% compared to prior year, led by strong growth from large corporate customers in the Americas and from the India market in International Gross margin of 34.4% was approximately flat compared to prior year despite higher tariff and restructuring costs Orders grew 6% compared to prior year, led by continued growth from large corporate customers in the AmericasGRAND RAPIDS, Mich., Sept. 24, 2025 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported second quarter revenue of $897.1 million, net income of $35.0 million, or $0.29 per share, and adjusted earnings per share of $0.45. In the prior year, Steelcase reported revenue of $855.8 million, net income of $63.1 million, or $0.53 per share, and adjusted earnings per share of $0.39. As previously announced, on August 3, 2025, the company entered into an Agreement...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.